Katarzyna Michalska, Stefan Tyski

Możliwość zastosowania nowych antybiotykow i chemioterapeutykow w leczeniu bakteryjnych zakażeń krwi

Newer treatment options with a particular focus on bloodstream infections

During the last decade several new antibacterial agents, such as: daptomycin, linezolid, quinupristin/dalfopristin, tigecycline, doripenem have been implemented into therapeutic use. Those compounds are especially effective against multidrug resistant pathogen. However, what is important, emergence of resistant bacteria and the shortage of new antimicrobial agents with activity against multidrug resistant Gram-negative pathogens, like: Pseudomonas aeruginosa and Acinetobacter baumannii have led to reconsideration of colistin as a valuable therapeutic option.
Keywords: bloodstream infections, daptomycin, linezolid, quinupristin/dalfopristin, tigecycline, doripenem, colistin.